Jacobio Pharmaceuticals Group Co Ltd
HKEX:1167
Income Statement
Earnings Waterfall
Jacobio Pharmaceuticals Group Co Ltd
Revenue
|
63.5m
CNY
|
Cost of Revenue
|
-60.3m
CNY
|
Gross Profit
|
3.2m
CNY
|
Operating Expenses
|
-390.7m
CNY
|
Operating Income
|
-387.5m
CNY
|
Other Expenses
|
28.4m
CNY
|
Net Income
|
-359.1m
CNY
|
Income Statement
Jacobio Pharmaceuticals Group Co Ltd
Dec-2020 | Jun-2021 | Dec-2021 | Jun-2022 | Dec-2022 | Jun-2023 | Dec-2023 | ||
---|---|---|---|---|---|---|---|---|
Revenue | ||||||||
Revenue |
486
N/A
|
544
+12%
|
153
-72%
|
150
-2%
|
96
-36%
|
81
-15%
|
64
-22%
|
|
Gross Profit | ||||||||
Cost of Revenue |
(44)
|
(97)
|
(140)
|
(133)
|
(83)
|
(75)
|
(60)
|
|
Gross Profit |
442
N/A
|
447
+1%
|
13
-97%
|
17
+33%
|
13
-26%
|
6
-51%
|
3
-48%
|
|
Operating Income | ||||||||
Operating Expenses |
(233)
|
(289)
|
(314)
|
(375)
|
(486)
|
(510)
|
(391)
|
|
Selling, General & Administrative |
(53)
|
(59)
|
(44)
|
(49)
|
(42)
|
(43)
|
(44)
|
|
Research & Development |
(181)
|
(231)
|
(277)
|
(336)
|
(441)
|
(468)
|
(351)
|
|
Depreciation & Amortization |
(5)
|
(7)
|
(5)
|
0
|
(6)
|
0
|
(24)
|
|
Other Operating Expenses |
7
|
7
|
11
|
9
|
2
|
1
|
28
|
|
Operating Income |
209
N/A
|
157
-25%
|
(302)
N/A
|
(358)
-19%
|
(474)
-32%
|
(504)
-6%
|
(388)
+23%
|
|
Pre-Tax Income | ||||||||
Interest Income Expense |
(28)
|
(35)
|
0
|
66
|
102
|
93
|
28
|
|
Non-Reccuring Items |
0
|
0
|
0
|
0
|
0
|
0
|
1
|
|
Total Other Income |
(1 695)
|
(962)
|
0
|
0
|
0
|
0
|
0
|
|
Pre-Tax Income |
(1 514)
N/A
|
(839)
+45%
|
(301)
+64%
|
(292)
+3%
|
(372)
-27%
|
(410)
-10%
|
(359)
+12%
|
|
Net Income | ||||||||
Tax Provision |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
Income from Continuing Operations |
(1 514)
|
(839)
|
(301)
|
(292)
|
(372)
|
(410)
|
(359)
|
|
Income to Minority Interest |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
Net Income (Common) |
(1 514)
N/A
|
(839)
+45%
|
(301)
+64%
|
(292)
+3%
|
(372)
-27%
|
(410)
-10%
|
(359)
+12%
|
|
EPS (Diluted) |
-1.99
N/A
|
-1.11
+44%
|
-0.4
+64%
|
-0.39
+3%
|
-0.49
-26%
|
-0.54
-10%
|
-0.46
+15%
|